click below
click below
Normal Size Small Size show me how
Molecular
First Aid - Biochem - Molecular
Question | Answer |
---|---|
chromatin structure | DNA exists in the condensed chromatin form to fit into the nucleus -negatively charged DNA loops twice around positively charged histone octamer (2 sets of H2A, H2B, H3 and H4) to form a nucleosome bead -- HI ties nucleosome beads together in a string |
heterochromatin | condensed, transcriptionally inactive, and sterically inaccessible |
euchromatin | less condensed, transcriptionally active and sterically accessible |
nucleotides | PURe As Gold: purines = adenine and guanine CUT the PY = pyrimidines = cytosine and thymine ---deamination of cytosine = uracil (RNA) G-C (3 H bonds) stronger than A-T (2 H bonds), so ^ G-C content means a higher melting temperature |
purine salvage deficiencies | nucleic acids > GMP > guanosine >< guanine > xanthine > uric acid AMP > adenosine > inosine >< hypoxanthine > xanthine > uric acid |
adenosine deaminase deficiency | excess ATP and dATP imbalance makes due to feedback inhibition of ribonucleotide reductase > prevents DNA synthesis and decreases lymphocyte count > major cause of severe combined immunodeficiency disorder |
lesch-nyhan syndrome | defective purine salvage owing to absence of HGPRT, this converts hypoxanthine to IMP and guanine to GMP. results in excess uric acid production > retardation, self-mutilation, aggression, gout, hyperuricemia, choreoathetosis |
Amino Acids - purine synthesis | GAG = glycine, aspartate, and glutamine are all necessary -Purines are made from IMP precursor |
Pyrimidine synthesis | pyrimidines are made from orotate precursor, with PRPP added later -ribonucleotides are synthesized first and are converted to deoxyribonucleotides by ribonucleotide reductase |
pyrimidine synthesis 2 | carbamoyl phosphate involved in de no pyr. syn and urea cycle, ornithine transcarbamoylase deficiency leads to an accumulation of carbamoyl phopsphate > converted to orotic acid |
drugs that interfere with nucleotide synthesis | Hydroxyurea = inhibits ribonucleotide reductase, 6-mercaptopurine = blocks de novo purine syn ,5-fluorouracil - inhibits thymidylate synthase, Methotrexate = inhibits dihydrofolate reductase, Trimethoprin = inhibits bacterial dihydrofolate reductase) las3 |
salvage path - nucleoside and nucleotides | salvage pathway = recover bases and nucleosides formed during DNA or RNA degradation, nucleosides (hypoxanthine, guanine, adenine) and nucleotides (IMP, AMP, GMP) |
DNA replication - origin | particular sequence in genome where DNA replication begins |
DNA replication - replication fork | Y shaped region along DNA template where leading and lagging strands are synthesized |
DNA replication - helicase | unwinds DNA template at replication fork |
DNA replication - single-stranded binding proteins | prevents strand from reannealing |
DNA replication - DNA topoisomerases | create a nick in the helix to relieve supercoils created during replication |
DNA replication - primase | makes an RNA primer to which DNA polymerase III can initiate replication |
DNA replication - DNA polymerase III | prokaryotic - elongates leading strand by adding deoxynucleotides to the 3' end -- elongates lagging strand until it reaches primer of preceding fragment. 3' exonuclease proofreads each nucleotide |
DNA replicaiton - DNA polymerase I | prokaryotic -- degrades RNA primer and fills in the gap with DNA |
DNA replicaiton - DNA ligase | seals the DNA |
DNA rep - Step 1 | helicases unwind the parental DNA double helix |
DNA rep - Step 2 | single strand binding proteins stabilize the unwound parental DNA |
DNA rep - Step 3 | the leading strand is syn continuously in the 5' - 3' by DNA polymerase |
DNA rep - Step 4 | lagging strand syn discontinuously - primase synthesize short RNA primers that is extended by DNA polymerase to form an Okazaki fragment |
DNA rep - Step 5 | RNA primer replaced by DNA by another DNA polymerase and DNA ligase puts together the Okazaki fragments to growing strand |
Fluroquinolones | inhibit DNA gyrase (a specific prokaryotic topoisomerase) |
Methods of single strand DNA repair | nucleotide excision repair, base excision repair, and mismatch repair |
Methods of double strand DNA repair | nonhomologous end joining |
nucleotide excision repair | specific endonucleases release the oligonucleotide containing damaged bases, DNA polymerase and ligase fill and reseal the gap, respectively |
Xeroderma pigmentosum - nucleotide excision repair | no nucleotide excision repair - prevents repair of thymidine dimers from UV light > results in dry skin with melanoma and other cancers |
Base excision repair | specific glycosylases recognize and remove damaged bases, AP endonuclease cuts DNA at apyrimidine site, empty sugar is removed, and the gap is filled and resealed |
Mismatch repair | unmethylated, newly synthesized string is recognized, mismatched nucleotides are removed and the gap is filled and resealed (mutated in HNPCC/Lynch) hMLH1 mutation (microsatellite instability) |
Nonhomologous end joining | brings together 2 ends of DNA fragments -- no requirement for homology (error prone - can lead to translocations and telomere fusions) |
DNA/RNA/protein synthesis direction | 5' - 3' / DNA syn requires a free 3' OH at add the next nucleotide -- drugs blocking DNA replication often have a modified 3' OH preventing addition of the next nucleotide (chain termination) |
Functional organization of the gene | 5' promoter, enhancer, promoter (TATA), transcription initiation site, Coding Region (exon/intron) , AATAAA 3' |
Promoter | site where RNA polymerase and multiple other transcription factors bind to DNA upstream from gene locus (AT-rich upstream sequence with TATA and CAAT boxes *mutation = dramatic decrease in amount gene transcribed |
Enhancer | stretch of DNA that alters gene expression by binding transcription factors - (enhancers and silencers may be located close to far from or even within (in an intron) the gene whose expression it regulates |
Silencer | site where negative regulators (repressors) bind |
RNA processing | Nucleus: after transcription 1. capping on 5' end (7-methylguanosine) 2. polyadenylation on 3'end 3. splicing out of introns *capped and tailed transcript = mRNA - transported out of nucleus (AAUAAA polyadenylation signal) |
Introns | Introns are intervening noncoding segments of the DNA - stay in the nucleus |
Exons | contain the actual genetic information coding for protein, exons exit and are expressed |
Alternative splicing (ex. Beta-Thal mutations) | different exons can be combined by alternative splicing to make unique proteins in different tissues (Beta-Thal mutations) |
tRNA structure | secondary structure, cloverleaf formation, CCA at 3' end along with high % of chemically modified bases - amino acid covalently bound to 3' end of tRNA |
tRNA charging | aminoacyl-tRNA synthestase examines aa before and after it binds, incorrect bond hydrolyzed, aa-tRNA energy for formation of peptide bond, mischarged tRNA reads usual codon but inserts wrong aa |
Tetracyclines | aminoacyl-tRNA synthetase and binding of charged tRNA to the codon are responsible for accuracy of aa selection - Tetracyclines bind 30s subunit preventing attachment of aminoacyl-tRNA |
protein synthesis - initiation | activated by GTP hydrolysis, initiation factors assemble 40S ribosomal subunit with initiator tRNA and released when mRNA and ribosomal subunit assemble with the complex |
protein synthesis - elongation | 1. aminoacyl-tRNA binds to A site 2. ribosomal rRNA catalyzes peptide bond formation transfers growing polypeptide to aa in A site 3. ribosome advances 3 nucleotides toward 3' end of RNA, moves peptidyl RNA to P site |
protein synthesis - termination | completed protein is released from ribosome through hydrolysis and dissociates |
protein synthesis inhibitors | Clindamycin = binds 50S blocking translocation |
Posttranslational modifications | trimming(removal of N or C terminal propeptides from zymogens to generate mature proteins), covalent alt(phosphorylation, glycosylation, hydroxylation), proteasome degradation(ubiquitin to defective proteins tagged for breakdown) |